TrialClinical cancer research : an official journal of the American Association for Cancer Research2024

Phase II Trial of HER-Vaxx, a B-cell Peptide-Based Vaccine, in HER2-Overexpressing Advanced Gastric Cancer Patients Under Platinum-Based Chemotherapy (HERIZON).

Joshua Tobias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.